Thalidomide is rapidly metabolized in hemodialysis patients and has a 3-fold increase in clearance during dialysis.
(2002) 35th Annual Meeting. American Society of Nephrology In Journal of the American Society of Nephrology 13(Suppl S). p.641-641
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/326072
- author
- Don, BR ; Vu, JT ; Eriksson, Tommy LU ; Scheffler, M and Kaysen, GA
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of the American Society of Nephrology
- volume
- 13
- issue
- Suppl S
- pages
- 641 - 641
- publisher
- Wolters Kluwer Health
- conference name
- 35th Annual Meeting. American Society of Nephrology
- conference location
- Philadelphia, Pa, United States
- conference dates
- 2002-10-30 - 2002-11-04
- external identifiers
-
- wos:000177757503133
- ISSN
- 1046-6673
- language
- English
- LU publication?
- yes
- id
- c96c4628-7ea4-4768-911f-3808d2ccc333 (old id 326072)
- date added to LUP
- 2016-04-01 15:50:50
- date last changed
- 2025-04-04 13:51:42
@misc{c96c4628-7ea4-4768-911f-3808d2ccc333,
author = {{Don, BR and Vu, JT and Eriksson, Tommy and Scheffler, M and Kaysen, GA}},
issn = {{1046-6673}},
language = {{eng}},
note = {{Conference Abstract}},
number = {{Suppl S}},
pages = {{641--641}},
publisher = {{Wolters Kluwer Health}},
series = {{Journal of the American Society of Nephrology}},
title = {{Thalidomide is rapidly metabolized in hemodialysis patients and has a 3-fold increase in clearance during dialysis.}},
volume = {{13}},
year = {{2002}},
}